A new study by Lund University shows that antihistamines may improve survival in patients with malignant melanoma.
In the study, the researchers investigated the use of six antihistamines in patients diagnosed with severe skin cancer. They observed improved survival and a reduced risk with two of the substances used. The use of the other antihistamines showed no significant effect on survival.
The research team now plans to conduct animal trials and randomised studies to understand the mechanisms behind the effect, the appropriate dose and the optimal duration of treatment.
References:
Lund University, Sweden
https://www.lunduniversity.lu.se/article/antihistamines-may-help-patients-with-malignant-melanoma